共 58 条
Time-lapse culture with morphokinetic embryo selection improves pregnancy and live birth chances and reduces early pregnancy loss: a meta-analysis
被引:147
作者:
Csaba, Pribenszky
[1
]
Nilselid, Anna-Maria
[2
]
Montag, Markus
[3
]
机构:
[1] Univ Vet Sci, Istvan U 2, H-1078 Budapest, Hungary
[2] Vitrolife Sweden AB, Box 9080, SE-40092 Gothenburg, Sweden
[3] Ilabcomm GmbH, Eisenachstr 34, D-53757 St Augustin, Germany
关键词:
Algorithm;
Embryo evaluation;
Embryo selection;
Morphokinetics;
Single embryo transfer;
Time-lapse imaging;
ASSISTED REPRODUCTIVE TECHNOLOGY;
HUMAN PREIMPLANTATION EMBRYOS;
OUTCOMES FOLLOWING SELECTION;
SINGLE BLASTOCYST;
IN-VITRO;
IMPLANTATION;
MORPHOLOGY;
SYSTEM;
IVF;
FERTILIZATION;
D O I:
10.1016/j.rbmo.2017.06.022
中图分类号:
R71 [妇产科学];
学科分类号:
100211 ;
摘要:
Embryo evaluation and selection is fundamental in clinical IVF. Time-lapse follow-up of embryo development comprises undisturbed culture and the application of the visual information to support embryo evaluation. A meta-analysis of randomized controlled trials was carried out to study whether time-lapse monitoring with the prospective use of a morphokinetic algorithm for selection of embryos improves overall clinical outcome (pregnancy, early pregnancy loss, stillbirth and live birth rate) compared with embryo selection based on single time-point morphology in IVF cycles. The meta-analysis of five randomized controlled trials (n = 1637) showed that the application of time-lapse monitoring was associated with a significantly higher ongoing clinical pregnancy rate (51.0% versus 39.9%), with a pooled odds ratio of 1.542 (P < 0.001), significantly lower early pregnancy loss (15.3% versus 21.3%; OR: 0.662; P = 0.019) and a significantly increased live birth rate (44.2% versus 31.3%; OR 1.668; P = 0.009). Difference in stillbirth was not significant between groups (4.7% versus 2.4%). Quality of the evidence was moderate to low owing to inconsistencies across the studies. Selective application and variability were also limitations. Although time-lapse is shown to significantly improve overall clinical outcome, further high-quality evidence is needed before universal conclusions can be drawn. (C) 2017 The Author(s). Published by Elsevier Ltd on behalf of Reproductive Healthcare Ltd.
引用
收藏
页码:511 / 520
页数:10
相关论文